• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (65)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Neurology  • Alzheimer Disease  • Cerebrovascular Disease  • Cognitive Disorders  • Dementias  • Neurogenetics  • Psychiatry  • Depression  • Public Health  • Exercise  • Review  • Diet  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Laura E. Middleton, PhD; Kristine Yaffe, MD

Arch Neurol. 2009;66(10):1210-1215.

The incidence and prevalence of dementia are expected to increase several-fold in the coming decades. Given that the current pharmaceutical treatment of dementia can only modestly improve symptoms, risk factor modification remains the cornerstone for dementia prevention. Some of the most promising strategies for the prevention of dementia include vascular risk factor control, cognitive activity, physical activity, social engagement, diet, and recognition of depression. In observational studies, vascular risk factors—including diabetes, hypertension, dyslipidemia, and obesity—are fairly consistently associated with increased risk of dementia. In addition, people with depression are at high risk for cognitive impairment. Population studies have reported that intake of antioxidants or polyunsaturated fatty acids may be associated with a reduced incidence of dementia, and it has been reported that people who are cognitively, socially, and physically active have a reduced risk of cognitive impairment. However, results from randomized trials of risk factor modification have been mixed. Most promising, interventions of cognitive and physical activity improve cognitive performance and slow cognitive decline. Future studies should continue to examine the implication of risk factor modification in controlled trials, with particular focus on whether several simultaneous interventions may have additive or multiplicative effects.

Author Affiliations: Departments of Psychiatry (Drs Middleton and Yaffe), Neurology (Dr Yaffe), and Epidemiology and Biostatistics (Dr Yaffe), School of Medicine, University of California, San Francisco, and the San Francisco Veterans Affairs Medical Center, San Francisco.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Targets of the Peroxisome Proliferator–Activated Receptor Agonist Trials for the Prevention of Alzheimer Disease—Reply
David S. Geldmacher, Thomas Fritsch, and Gary E. Landreth
Arch Neurol. 2011;68(4):542-543.
EXTRACT | FULL TEXT  

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(10):1190-1191.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Total and Specific Polyphenol Intakes in Midlife Are Associated with Cognitive Function Measured 13 Years Later
Kesse-Guyot et al.
J. Nutr. 2012;142:76-83.
ABSTRACT | FULL TEXT  

French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial
Kesse-Guyot et al.
Am J Clin Nutr 2011;94:892-899.
ABSTRACT | FULL TEXT  

Lifelong Low-Phylloquinone Intake Is Associated with Cognitive Impairments in Old Rats
Carrie et al.
J. Nutr. 2011;141:1495-1501.
ABSTRACT | FULL TEXT  

Activity Energy Expenditure and Incident Cognitive Impairment in Older Adults
Middleton et al.
Arch Intern Med 2011;171:1251-1257.
ABSTRACT | FULL TEXT  

Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial
Andreeva et al.
Am J Clin Nutr 2011;94:278-286.
ABSTRACT | FULL TEXT  

Achieving Ideal Cardiovascular and Brain Health: Opportunity Amid Crisis: Presidential Address at the American Heart Association 2010 Scientific Sessions
Sacco
Circulation 2011;123:2653-2657.
FULL TEXT  

Mild Cognitive Impairment, Dementia, and Their Subtypes in Oldest Old Women
Yaffe et al.
Arch Neurol 2011;68:631-636.
ABSTRACT | FULL TEXT  

Targets of the Peroxisome Proliferator-Activated Receptor {gamma} Agonist Trials for the Prevention of Alzheimer Disease--Reply
Geldmacher et al.
Arch Neurol 2011;68:542-543.
FULL TEXT  

Preclinical Alzheimer Disease: Prevention Holy Grail or Pandora's Box?: Comment on "Heavy Smoking in Midlife and Long-term Risk of Alzheimer Disease and Vascular Dementia"
Yaffe
Arch Intern Med 2011;171:339-340.
FULL TEXT  

Frontiers in Alzheimer's disease therapeutics
Stone et al.
Therapeutic Advances in Chronic Disease 2011;2:9-23.
ABSTRACT  

Treatment of Alzheimer Disease and Prognosis of Dementia: Time to Translate Research to Results
Yaffe
JAMA 2010;304:1952-1953.
FULL TEXT  

Is There a Connection Between Diabetes and Psychological Dysfunction?
Terre
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2010;4:481-483.
ABSTRACT  

Alzheimer disease prevention: Focus on cardiovascular risk, not amyloid?
GELDMACHER
Cleveland Clinic Journal of Medicine 2010;77:689-704.
ABSTRACT | FULL TEXT  

Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors
Ritchie et al.
BMJ 2010;341:c3885-c3885.
ABSTRACT | FULL TEXT